Search research articles
Contact Us
Filters
Showing results (41-50 of 67) with videos related to
Page
of 7
Sort By:
Oncology Reports
|
November 20, 2013
Diethylstilbestrol for the treatment of patients with castration-resistant prostate cancer: retrospective analysis of a single institution experience
Tal Grenader, Yevgeni Plotkin, Maya Gips, et al.
Harefuah
|
February 3, 2006
[Metastatic testicular cancer presenting with venous thromboembolism]
Tal Grenader, Orit Gutfeld, Linda Shavit, et al.
The Mount Sinai Journal of Medicine, New York
|
September 30, 2006
Aortic occlusion in patients treated with Cisplatin-based chemotherapy
Tal Grenader, Linda Shavit, Inna Ospovat, et al.
Clinical Genitourinary Cancer
|
December 26, 2012
Spontaneous regression of metastatic papillary renal cell cancer after cessation of treatment with sorafenib
Tal Grenader, Eli Rosenbaum, Sofia Zilber, et al.
World Journal of Clinical Oncology
|
December 1, 2012
Pegylated liposomal doxorubicin/carboplatin combination in ovarian cancer, progressing on single-agent pegylated liposomal doxorubicin
Tal Grenader, Ora Rosengarten, Rut Isacson, et al.
International Urology and Nephrology
|
February 20, 2007
Brain metastases: a rare initial presentation of prostate cancer
Tal Grenader, Linda Shavit, Alexander Lossos, et al.
Tumori
|
February 8, 2013
Abdominal cocoon: a potential pitfall in patients with ovarian carcinoma
Rut Isacson, Amiel Segal, Joseph Alberton, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 13, 2017
The prognostic value of derived neutrophil to lymphocyte ratio in oesophageal cancer treated with definitive chemoradiotherapy
Samantha Cox, Christopher Hurt, Tal Grenader, et al.
Tumori
|
March 10, 2010
Mitomycin C and vinblastine: an active regimen in previously treated breast cancer patients
Inna Ospovat, Nava Siegelmann-Danieli, Tal Grenader, et al.
Familial Cancer
|
August 6, 2008
Absence of founder BRCA1 and BRCA2 mutations in cutaneous malignant melanoma patients of Ashkenazi origin
Luna Kadouri, Mark Temper, Tal Grenader, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 67) with videos related to
Sort By:
Page
of 7
Oncology Reports
|
November 20, 2013
Diethylstilbestrol for the treatment of patients with castration-resistant prostate cancer: retrospective analysis of a single institution experience
Tal Grenader, Yevgeni Plotkin, Maya Gips, et al.
Harefuah
|
February 3, 2006
[Metastatic testicular cancer presenting with venous thromboembolism]
Tal Grenader, Orit Gutfeld, Linda Shavit, et al.
The Mount Sinai Journal of Medicine, New York
|
September 30, 2006
Aortic occlusion in patients treated with Cisplatin-based chemotherapy
Tal Grenader, Linda Shavit, Inna Ospovat, et al.
Clinical Genitourinary Cancer
|
December 26, 2012
Spontaneous regression of metastatic papillary renal cell cancer after cessation of treatment with sorafenib
Tal Grenader, Eli Rosenbaum, Sofia Zilber, et al.
World Journal of Clinical Oncology
|
December 1, 2012
Pegylated liposomal doxorubicin/carboplatin combination in ovarian cancer, progressing on single-agent pegylated liposomal doxorubicin
Tal Grenader, Ora Rosengarten, Rut Isacson, et al.
International Urology and Nephrology
|
February 20, 2007
Brain metastases: a rare initial presentation of prostate cancer
Tal Grenader, Linda Shavit, Alexander Lossos, et al.
Tumori
|
February 8, 2013
Abdominal cocoon: a potential pitfall in patients with ovarian carcinoma
Rut Isacson, Amiel Segal, Joseph Alberton, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 13, 2017
The prognostic value of derived neutrophil to lymphocyte ratio in oesophageal cancer treated with definitive chemoradiotherapy
Samantha Cox, Christopher Hurt, Tal Grenader, et al.
Tumori
|
March 10, 2010
Mitomycin C and vinblastine: an active regimen in previously treated breast cancer patients
Inna Ospovat, Nava Siegelmann-Danieli, Tal Grenader, et al.
Familial Cancer
|
August 6, 2008
Absence of founder BRCA1 and BRCA2 mutations in cutaneous malignant melanoma patients of Ashkenazi origin
Luna Kadouri, Mark Temper, Tal Grenader, et al.
Page
of 7